126 related articles for article (PubMed ID: 25119060)
1. Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantation‑induced tumor growth.
Huang X; Qin J; Lu S
Mol Med Rep; 2014 Oct; 10(4):2153-9. PubMed ID: 25119060
[TBL] [Abstract][Full Text] [Related]
2. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
3. Fuzheng Qingjie Granules Inhibit Growth of Hepatoma Cells via Inducing Mitochondria-Mediated Apoptosis and Enhancing Immune Function.
Chen X; Cao Z; Zhang Y; Li J; Wang S; Du J; Liao L
Integr Cancer Ther; 2017 Sep; 16(3):329-338. PubMed ID: 27335087
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma.
Pan P; Wu Y; Guo ZY; Wang R; Wang YJ; Yuan YF
J Ethnopharmacol; 2012 Sep; 143(2):680-5. PubMed ID: 22867634
[TBL] [Abstract][Full Text] [Related]
5. Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cells.
Shu G; Yang T; Wang C; Su H; Xiang M
Toxicol Appl Pharmacol; 2013 Jun; 269(3):270-9. PubMed ID: 23578476
[TBL] [Abstract][Full Text] [Related]
6. CD8
Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
[TBL] [Abstract][Full Text] [Related]
7. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Hwang KS; Cho WK; Yoo J; Seong YR; Kim BK; Kim S; Im DS
Cancer Gene Ther; 2004 Jun; 11(6):397-407. PubMed ID: 15044962
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells.
Sprinzl MF; Reisinger F; Puschnik A; Ringelhan M; Ackermann K; Hartmann D; Schiemann M; Weinmann A; Galle PR; Schuchmann M; Friess H; Otto G; Heikenwalder M; Protzer U
Hepatology; 2013 Jun; 57(6):2358-68. PubMed ID: 23424039
[TBL] [Abstract][Full Text] [Related]
11. Anti-Tumor Effects of the Polysaccharide Isolated from Tarphochlamys Affinis in H22 Tumor-Bearing Mice.
Tang X; Huang J; Xiong H; Zhang K; Chen C; Wei X; Xu X; Xie Q; Huang R
Cell Physiol Biochem; 2016; 39(3):1040-50. PubMed ID: 27537353
[TBL] [Abstract][Full Text] [Related]
12. A Huaier polysaccharide inhibits hepatocellular carcinoma growth and metastasis.
Li C; Wu X; Zhang H; Yang G; Hao M; Sheng S; Sun Y; Long J; Hu C; Sun X; Li L; Zheng J
Tumour Biol; 2015 Mar; 36(3):1739-45. PubMed ID: 25374064
[TBL] [Abstract][Full Text] [Related]
13. Experimental study on the effect of Kang-Lai-Te induced apoptosis of human hepatoma carcinoma cell HepG2.
Lu Y; Wu LQ; Dong Q; Li CS
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):267-72. PubMed ID: 19502166
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells.
Dong X; Liu F; Li M
Anticancer Drugs; 2016 Apr; 27(4):286-99. PubMed ID: 26704389
[TBL] [Abstract][Full Text] [Related]
15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
[TBL] [Abstract][Full Text] [Related]
16. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice.
Kan X; Zhang W; You R; Niu Y; Guo J; Xue J
BMC Complement Altern Med; 2017 Jan; 17(1):41. PubMed ID: 28086772
[TBL] [Abstract][Full Text] [Related]
17. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
Shin S; Kim M; Lee SJ; Park KS; Lee CH
Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory NHE-06 restores antitumor immunity by targeting NF-κB/IL-6/STAT3 signaling in hepatocellular carcinoma.
Lu X; Wo G; Li B; Xu C; Wu J; Jiang C; Wei J
Biomed Pharmacother; 2018 Jun; 102():420-427. PubMed ID: 29574282
[TBL] [Abstract][Full Text] [Related]
19. Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro.
Chen YL; Yan MY; Chien SY; Kuo SJ; Chen DR; Cheng CY; Su CC
Mol Med Rep; 2013 May; 7(5):1487-93. PubMed ID: 23525225
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
